Rapid response to a single-dose rituximab combined with bortezomib in refractory and relapsed warm autoimmune hemolytic anemia
Sign Up to like & getrecommendations! Published in 2020 at "Annals of Hematology"
DOI: 10.1007/s00277-020-03976-w
Abstract: Dear Editor, Autoimmune hemolytic anemia (AIHA) is an autoantibodymediated anemia in which the immune system attacks and destroys red blood cells. Of patients with AIHA, 70–80% are classified as having warm AIHA (wAIHA) according to… read more here.
Keywords: rituximab; anemia; autoimmune hemolytic; response ... See more keywords
Efficacy of rituximab combined with CHOP for treating patients with diffuse large B-cell lymphoma
Sign Up to like & getrecommendations! Published in 2017 at "Medicine"
DOI: 10.1097/md.0000000000008494
Abstract: Background: This study aimed to evaluate the efficacy and safety of rituximab combined with cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) for treating patients with diffuse large B-cell lymphoma (DLBCL). Methods: A total of 144 patients… read more here.
Keywords: group; efficacy; intervention group; chop ... See more keywords
Early treatment of rituximab combined with eltrombopag for secondary thrombocytopenic purpura in rheumatoid arthritis
Sign Up to like & getrecommendations! Published in 2022 at "Medicine"
DOI: 10.1097/md.0000000000028417
Abstract: Abstract Rationale: Secondary immune thrombocytopenic purpura (ITP) is also known as acquired thrombocytopenic purpura, autoimmune disease is usually one of the important causes. There are few reports about treatment of refractory thrombocytopenic purpura in rheumatoid… read more here.
Keywords: rituximab combined; purpura rheumatoid; rheumatoid arthritis; treatment ... See more keywords